Skip to main content
. 2019 Apr;10(2):226–234. doi: 10.21037/jgo.2018.12.10

Figure 4.

Figure 4

Survival curve of 2-year disease-free survival (DFS) in patients with colon cancer treated with oxaliplatin-containing adjuvant chemotherapy based on histological grade. Patients with well differentiated and moderately-poorly differentiated tumors had 2-year DFS of 85.1% and 66.9% (HR =3.503; 95% CI, 1.403–8.744; P=0.007).